| scholarly article | Q13442814 |
| P50 | author | Gin Malhi | Q89872646 |
| Pritha Das | Q61268320 | ||
| P2093 | author name string | Claire McAulay | |
| Kristina Fritz | |||
| P2860 | cites work | Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder | Q28250466 |
| Treatment of bipolar disorder | Q28290437 | ||
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders | Q30583384 | ||
| The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD. | Q31171961 | ||
| Medicating mood with maintenance in mind: bipolar depression pharmacotherapy | Q33470676 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial | Q34012103 | ||
| Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials | Q34197988 | ||
| Lamotrigine: a review of its use in bipolar disorder | Q34228876 | ||
| Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). | Q34230151 | ||
| Maintenance therapies in bipolar disorders | Q34268760 | ||
| Carbamazepine treatment of bipolar disorder: a retrospective evaluation of naturalistic long-term outcomes | Q34278852 | ||
| Potential mechanisms of action of lithium in bipolar disorder. Current understanding | Q34325612 | ||
| Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis | Q34349641 | ||
| Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q34564599 | ||
| Clinical practice recommendations for bipolar disorder | Q34606360 | ||
| Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial | Q34616063 | ||
| Aripiprazole in the acute and maintenance phase of bipolar I disorder | Q35717037 | ||
| A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders | Q36513316 | ||
| The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole | Q36996674 | ||
| A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder | Q37827220 | ||
| Quetiapine for bipolar depression: a systematic review and meta-analysis | Q37959590 | ||
| The science and practice of lithium therapy | Q37990676 | ||
| Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder | Q38003196 | ||
| The clinical management of bipolar disorder complexity using a stratified model | Q38003199 | ||
| Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder. | Q38167386 | ||
| Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial | Q38376022 | ||
| Risk factors for antidepressant-related switch to mania. | Q38474943 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). | Q42672212 | ||
| Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder | Q43130555 | ||
| A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently | Q43239518 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode | Q45750933 | ||
| Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study | Q48466826 | ||
| A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression | Q48886100 | ||
| Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design | Q48910862 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| pharmacotherapy | Q701216 | ||
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2014-08-27 | |
| P1433 | published in | Evidence-Based Mental Health | Q5418311 |
| P1476 | title | Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy | |
| P478 | volume | 18 |
| Q47376705 | Associations between mood instability and emotional processing in a large cohort of bipolar patients |
| Q89498649 | Development and pilot of a decision-aid for patients with bipolar II disorder and their families making decisions about treatment options to prevent relapse |
| Q47693761 | Early intervention for bipolar disorder in adolescents: A psychosocial perspective. |
| Q99563452 | Improving treatment decision-making in bipolar II disorder: a phase II randomised controlled trial of an online patient decision-aid |
| Q57471124 | Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study |
| Q54288033 | Mood instability and regulatory oversight: Checkpoints on the pursuit of 'true' mood stabilisers. |
| Q59136749 | Phase II Randomised Controlled Trial of a patient decision-aid website to improve treatment decision-making for young adults with bipolar II disorder: A feasibility study protocol |
| Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
Search more.